Literature DB >> 31270722

Receiver operating characteristic analysis of ultrasound joint inflammation in relation to structural damage and disease activity in rheumatoid arthritis.

HuiHua Li1, John Carson Allen2, Julian Thumboo3,4,5, York Kiat Tan6,7,8.   

Abstract

OBJECTIVE: To investigate whether ultrasound greyscale (GS) and power Doppler (PD) joint inflammation may be useful in identifying rheumatoid arthritis (RA) patients in different states of structural damage and disease activity.
METHODS: In this cross-sectional study utilizing 36-joint ultrasonography, bone erosion was scored dichotomously (1 = yes/0 = no) while GS and PD joint inflammations were graded semi-quantitatively (0-3) at each joint recess. Sensitivity, specificity and receiver operating characteristic (ROC) curve analysis was applied to study ultrasound joint inflammation as a clinical marker for identifying patients with erosion score > 4.5 (median) and DAS28 > 2.6, > 3.2 and > 5.1, respectively.
RESULTS: 1080 joints and 1800 joint recesses were scanned in 30 RA patients (mean disease duration, 70.3 months). Patients with GS score > 35.5 (median) had significantly higher ultrasound erosion scores when compared to those with GS score ≤ 35.5 (mean (95% CI) ultrasound erosion scores, 9.27 (6.12-12.4) versus 3.33 (2.31-4.36), respectively. p = 0.0027). Patients with PD positivity had significantly higher DAS28 scores compared to those with PD negativity (mean (95% CI) DAS28, 3.84 (3.35, 4.34) versus 2.86 (2.18, 3.54), respectively. p = 0.0457). Area under the ROC curve (AUC) based on cut-off GS scores ≥ 38 to identify patients with ultrasound erosion score >4.5 was 0.82 (sensitivity = 73.3%, specificity = 86.7%, accuracy = 80%). AUC based on cut-off PD scores ≥ 2.5 for identifying patients with DAS28 > 5.1 was 0.88 (sensitivity = 100%, specificity = 69.2%, accuracy = 73.3%).
CONCLUSIONS: Ultrasound GS and PD joint inflammation scores can be useful in identifying RA patients with high bone erosion burden (ultrasound erosion score > 4.5) and high disease activity (DAS28 > 5.1), respectively.

Entities:  

Keywords:  Bone erosion; Joints; Rheumatoid arthritis; Synovitis; Ultrasound

Mesh:

Substances:

Year:  2019        PMID: 31270722     DOI: 10.1007/s11547-019-01063-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  19 in total

1.  Receiver operating characteristic curves and their use in radiology.

Authors:  Nancy A Obuchowski
Journal:  Radiology       Date:  2003-10       Impact factor: 11.105

Review 2.  Ultrasound and its clinical use in rheumatoid arthritis: where do we stand?

Authors:  Aline Defaveri do Prado; Henrique Luiz Staub; Melissa Cláudia Bisi; Inês Guimarães da Silveira; José Alexandre Mendonça; Joaquim Polido-Pereira; João Eurico Fonseca
Journal:  Adv Rheumatol       Date:  2018-08-02

3.  American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice.

Authors:  Timothy McAlindon; Eugene Kissin; Levon Nazarian; Veena Ranganath; Shraddha Prakash; Mihaela Taylor; Raveendhara R Bannuru; Sachin Srinivasan; Maneesh Gogia; Maureen A McMahon; Jennifer Grossman; Suzanne Kafaja; John FitzGerald
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

Review 4.  Imaging in rheumatoid arthritis.

Authors:  York Kiat Tan; Philip G Conaghan
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-08       Impact factor: 4.098

5.  Musculoskeletal ultrasound including definitions for ultrasonographic pathology.

Authors:  Richard J Wakefield; Peter V Balint; Marcin Szkudlarek; Emilio Filippucci; Marina Backhaus; Maria-Antonietta D'Agostino; Esperanza Naredo Sanchez; Annamaria Iagnocco; Wolfgang A Schmidt; George A W Bruyn; George Bruyn; David Kane; Philip J O'Connor; Bernhard Manger; Fred Joshua; Juhani Koski; Walter Grassi; Marissa N D Lassere; Nanno Swen; Franz Kainberger; Andrea Klauser; Mikkel Ostergaard; Andrew K Brown; Klaus P Machold; Philip G Conaghan
Journal:  J Rheumatol       Date:  2005-12       Impact factor: 4.666

6.  Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis.

Authors:  Hilde Berner Hammer; Pernille Bolton-King; Vivi Bakkeheim; Torill Helene Berg; Elisabeth Sundt; Anne Katrine Kongtorp; Espen A Haavardsholm
Journal:  Ann Rheum Dis       Date:  2011-07-22       Impact factor: 19.103

7.  EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis.

Authors:  Alexandra N Colebatch; Christopher John Edwards; Mikkel Østergaard; Désirée van der Heijde; Peter V Balint; Maria-Antonietta D'Agostino; Kristina Forslind; Walter Grassi; Espen A Haavardsholm; Glenn Haugeberg; Anne-Grethe Jurik; Robert B M Landewé; Esperanza Naredo; Philip J O'Connor; Ben Ostendorf; Kristina Potocki; Wolfgang A Schmidt; Josef S Smolen; Sekib Sokolovic; Iain Watt; Philip G Conaghan
Journal:  Ann Rheum Dis       Date:  2013-03-21       Impact factor: 19.103

Review 8.  Monitoring in established RA: Role of imaging and soluble biomarkers.

Authors:  Joshua F Baker; York Kiat Tan; Philip G Conaghan
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-11-03       Impact factor: 4.098

9.  An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.

Authors:  A K Brown; P G Conaghan; Z Karim; M A Quinn; K Ikeda; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2008-10

10.  Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study.

Authors:  Maria-Antonietta D'Agostino; Richard J Wakefield; Hilde Berner-Hammer; Olivier Vittecoq; Georgios Filippou; Peter Balint; Ingrid Möller; Annamaria Iagnocco; Esperanza Naredo; Mikkel Østergaard; Maarten Boers; Corine Gaillez; Karina Van Holder; Manuela Le Bars
Journal:  Ann Rheum Dis       Date:  2015-11-20       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.